Weight loss research questions need for GLP-1 drugs
A new approach to weight loss research is challenging one of the biggest assumptions behind popular weight loss drugs: Are GLP-1s actually needed to achieve weight loss?
Apr 17, 2026
0
34
Clinical pharmacology news
This is your brain on psychedelics: Neuroimaging study sheds light on cortical network effects
Psychedelic drugs are being investigated as scientific and clinical tools, but the brain mechanisms behind their effects remain unclear. Earlier brain imaging studies in small cohorts from single centers produced inconsistent ...
Apr 6, 2026
0
33
No evidence to suggest medicinal cannabis is effective for depression, anxiety or PTSD, says systematic review
A landmark paper published in Lancet Psychiatry—the largest-ever review of the safety and efficacy of cannabinoids across a range of mental health conditions—found no evidence that medicinal cannabis is effective in treating ...
Mar 16, 2026
0
32
Psilocybin cuts nerve pain for weeks and boosts gabapentin in mice
A single dose of psilocybin, the active compound in magic mushrooms, reduces nerve pain for up to a month and makes a widely used painkiller work more effectively, University of Reading research has found.
May 22, 2026
0
32
Lithium not working? Large-scale study highlights favorable treatment strategies for bipolar disorder
Bipolar disorder is a mental health condition estimated to affect between 1% and 3% of people worldwide. Its main symptoms include extreme mood swings, ranging from periods of high activity and emotional high (i.e., mania) ...
Viagra could hold key to halting Peyronie's disease
Combining two widely prescribed drug classes could provide the first effective treatment for early-stage Peyronie's disease, according to a new study published in The Journal of Sexual Medicine.
May 14, 2026
0
31
GLP-1 medications used to treat diabetes and obesity may also help alleviate symptoms of anxiety and depression
GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness absence due to psychiatric reasons, a new study shows. The large register-based study was carried out ...
Mar 18, 2026
0
31
Could an anti-aging therapy worsen myelin loss? Findings raise caution and MS clues
A two-drug combination frequently used in anti-aging research causes brain damage in mice, report University of Connecticut researchers in the Proceedings of the National Academy of Sciences. The findings, titled "Senolytic ...
Mar 17, 2026
0
30
New drug doubles 1-year survival in pancreatic cancer trial
Pancreatic cancer is one of the deadliest cancers and among the hardest to treat, with most patients surviving less than a year after diagnosis. But a new drug developed at Northwestern University may soon help patients live ...
Apr 14, 2026
0
30
Some common IBS treatments are linked to a higher risk of death, say study
A large, long-term study led by Cedars-Sinai Health Sciences University investigators suggests that some medications commonly prescribed to treat irritable bowel syndrome (IBS)—including antidepressants—may be associated ...
Apr 8, 2026
0
30
